SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 28th, 2016 • Amarantus Bioscience Holdings, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of January 27, 2016, by and among Amarantus BioScience Holdings, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
STOCK REPURCHASE AGREEMENTStock Repurchase Agreement • January 28th, 2016 • Amarantus Bioscience Holdings, Inc. • Pharmaceutical preparations • New York
THIS STOCK REPURCHASE AGREEMENT (this “Agreement”) is entered into as of January 27, 2016 by and between Amarantus Bioscience Holdings, Inc., a Nevada corporation (the “Company”), and _______ (the “Selling Stockholder”).
LEAK-OUT AGREEMENTLeak-Out Agreement • January 28th, 2016 • Amarantus Bioscience Holdings, Inc. • Pharmaceutical preparations • New York
THIS LEAK-OUT AGREEMENT (the “Agreement”) is made and entered into as of the 27th day of January 2016, between Amarantus Bioscience Holdings, Inc., a Nevada corporation (the “Company”) and the holders (the “Holders” and each a “Holder”) of the Company’s issued and outstanding Series E Convertible Preferred Stock and Series H Convertible Preferred Stock (collectively, the “Preferred Stock”), 12% Senior Secured Convertible Promissory Notes, due September 29, 2016 (the “Notes”) or five year Common Stock Purchase Warrants (the “Warrants” and together with the Preferred Stock and Notes, the “Securities”) and
